← Back
Data updated: Mar 10, 2026
PROPEL PHARMA
Neurology
PROPEL PHARMA is a generic drug manufacturer focused on Neurology.
2021
Since
1
Drugs
-
Trials
26
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
VIGABATRIN 2024-12-17
Labeling
VIGABATRIN 2024-12-17
Labeling
VIGABATRIN 2024-10-23
Labeling
VIGABATRIN 2024-09-12
REMS
VIGABATRIN 2024-09-12
REMS
VIGABATRIN 2024-09-12
REMS
VIGABATRIN 2024-09-12
REMS
VIGABATRIN 2024-09-12
REMS
VIGABATRIN 2024-09-12
REMS
VIGABATRIN 2024-09-12
REMS
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2021-07-29
- Latest
- 2024-09-12
- Applications
- 1